Sergei A Tsarev

This inventor holds 3 USPTO granted patents. Top assignees: Institut Bioorganicheskoi Khimii Imeni M.m. Shemyakina Akademii Nauk Ssr, Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr, Vsesojuzny Nauchno-Issledovatelsky Institut Genetiki. Active years: 1987-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sergei A Tsarev. Retrieved from https://idiyas.com/inventor/sergei-a-tsarev-g06iva2n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 14.7

ph-index = 1

Forward Citations = 8(Granted Patents)

Company Filing History:

1 out of 1

Institut Bioorganicheskoi Khimii Imeni M.m. Shemyakina Akademii Nauk Ssr

patent

1 out of 7

Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr

patents

1 out of 1

Vsesojuzny Nauchno-Issledovatelsky Institut Genetiki

patent

4. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1987-1991

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4988622 - Recombinant plasmid DNA pVN 22 coding biosynthesis of human leukocyte (1991-01-29),

2. 4751287 - Human leukocyte interferon N and a method of producing same in bacterial (1988-06-14),

3. 4680260 - Method for producing human leukocyte interferon alpha-2 (1987-07-14),

Title: The Innovations of Sergei A. Tsarev

Introduction

Sergei A. Tsarev is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of genetics and biotechnology. With a total of 3 patents, his work has had a lasting impact on scientific research and development.

Latest Patents

One of his latest patents includes a recombinant plasmid DNA, pVN 22, which codes for the biosynthesis of human leukocyte interferon N. This invention also encompasses a method of producing the interferon in bacterial systems. His innovative approaches have paved the way for advancements in medical treatments and therapies.

Career Highlights

Throughout his career, Tsarev has worked with esteemed institutions such as the All-Union Research Institute of Genetics and the Institute of Organic Synthesis of the Academy of Sciences of the Latvian SSR. His experience in these organizations has allowed him to develop and refine his expertise in genetic engineering and biotechnology.

Collaborations

Tsarev has collaborated with notable colleagues, including Evgeny D. Sverdlov and Galina S. Monastyrskaya. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Sergei A. Tsarev's contributions to the field of genetics and biotechnology are commendable. His innovative patents and collaborations highlight his dedication to advancing scientific knowledge. His work continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]